Literature DB >> 3341917

Emphysematous pyelonephritis in a xanthogranulomatous kidney. An unusual cause of pneumoperitoneum.

L A Langdale1, C L Rice, N Brown.   

Abstract

Emphysematous pyelonephritis is a rare, life-threatening suppurative infection of the renal parenchyma and perinephric tissues. The disease is encountered primarily in patients with diabetes mellitus or ureteral obstruction associated with perinephric and intrarenal gas. Causative organisms are those normally found in the urinary and gastrointestinal tracts; however, anaerobic bacteria have been demonstrated in only 1% of cases. We describe a case of emphysematous pyelonephritis, which presented as an acute abdomen with pneumoperitoneum in a nondiabetic patient. No visceral injury was found at laparotomy. Multiple gas-producing organisms, including Clostridium ramosum (not previously reported, to our knowledge), were the cause of the free intraperitoneal and perinephric air. Subsequent radical nephrectomy revealed a xanthogranulomatous kidney. An aggressive surgical approach combined with intensive antibiotic therapy, after aerobic and anaerobic culture of excised tissue, is lifesaving.

Entities:  

Mesh:

Year:  1988        PMID: 3341917     DOI: 10.1001/archsurg.1988.01400270117019

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

1.  Is aggressive therapy the answer for all cases of emphysematous pyelonephritis: a report of three cases.

Authors:  Sidharth Kumar; Sushanto Neogi; Kamal K Gautam
Journal:  J Surg Tech Case Rep       Date:  2012-07

2.  Spondylodiscitis due to Clostridium ramosum infection in an immunocompetent elderly patient.

Authors:  Jean-Philippe Lavigne; Nicole Bouziges; Albert Sotto; Jean-Louis Leroux; Sylvie Michaux-Charachon
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

3.  Treatment of a case of emphysematous pyelonephritis that presented with acute abdomen and pneumoperitoneum: a case report.

Authors:  Sang Hyun Park; Ki Hoon Kim
Journal:  BMC Nephrol       Date:  2015-08-01       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.